TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Macular structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late Effects Normal Tissue Task Force (LENT)-SOMA scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of the pain visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuro-QoL cognitive
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: icognition Symbol test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: icognition Dot test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: icognition Digit test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: number of intradialytic hypotensive events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in global cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bone volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Global time spent in hypotension <10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Treated Participants Experiencing Grade 3 or Above Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of pulp tissue left behind
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Traumatic Catheterization Case Number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Visible abdominal distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in synchronization in the EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional connectivity between the thalamus and the cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choline concentrations in the occipital cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Venham Clinical Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RMS-Self Pictorial scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relative change in MRI-PDFF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter-related infectious complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 10-Meter Walk Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height of the periodontal bone defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Strength Assessment for Sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Seconds Sit To Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall patency rate of the grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Liver abscess formation
Endpoint domain: Adverse events/effects
Primary endpoint: Amplitude of change in plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of Plasma Interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain intensity (Using Numeric Rating Scale)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: early changes in ocular physiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Acute Hamstring Strain Injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Program feasibility
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Caregiver assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Social support effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: DREAMS Care Kit Usage Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention Assessment Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean number of days participants remain on study medication
Endpoint domain: Mortality/survival
Primary endpoint: Presence of rectal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Isokinetic proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amputee mobility predictor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-gE antibody concentrations expressed as group geometric mean concentration (GMC) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of RSV-A neutralizing titers expressed as group geometric mean titer (GMT) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of RSV-B neutralizing titers expressed as group GMT ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: improvement of nutritional status assessed by anthropometric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of nutritional status assessed by Bioelectrical Inbody Analysis (BIA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of nutritional status assessed by laboratory investigations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User Evaluation of Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional disability status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: acceptable clinical toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Dupilumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified visual analogue pain score (m-VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular End Systolic Volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Ventricular End Diastolic Volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Small intestine permeability changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevent intubation within 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IBS-SSS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding Self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infant Colic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microcirculatory vascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: variation of sample bacterial composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse or Severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in the International Index of Erectile Function Questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients receiving geriatric assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: neural development at 1 year old
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neural development at 2 years old
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neural development at 6 years old
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth and neural development at 12 years old
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth and neural development at 18 years old
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postpartum mother-baby attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bacterial translocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SDM competency from midwives' perspective
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: SDM competency from observers' perspective
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: SDM competency from patients' perspective
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Success rate of PFO effective occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of sleep disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of Vessel Transections With an Achievement of Grade 3 or Lower Hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants with Device-Related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Obstructive sleep apnea severity measured by AHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Immune response via blood draw pre-enrollment to ≥1 year post-transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse events after a 3rd dose of Shingrix
Endpoint domain: Adverse events/effects
Primary endpoint: gE-specific CMI via blood draw at 30-60 days after the 3rd dose of Shingrix
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence rate of bacteriologically positive TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of Clenbuterol-related adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Serum ammonia specificity and sensitivity in predicting sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVmax of the cavernous sinus lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with extracranial sites of involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to complete bone remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Valuation of dizziness with Dizziness Visual Analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluate vestibular-ocular reflex with Video head impulse test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Valuation of hearing threshold with pure tone audiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CKD-progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: CVD-outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal+CVD-outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Number of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lower extremity motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood Oxygen Level Dependent (BOLD) signal change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the WOMAC Osteoarthritis Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Satiety Quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median radiographic progression-free survival (rPFS) at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Number of discontinuations due to Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Nicotine Metabolic Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cessation of Abnormal Postpartum Uterine Bleeding or Hemorrhaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Difference in methemoglobin after ferric derisomaltose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in methemoglobin after ferric carboxymaltose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Learning rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of frequency of acute respiratory infection (ARI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change of frequency of diarrheal disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Teachers' level of knowledge about infant mental health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of the intervention assessed by the proportion of teachers who complete the workshop
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction assessed by a Likert Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of accuracy for referral of children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication skills development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: American Spinal Injury Association (ASIA) Upper-Extremity Motor Score (UEMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASIA Upper-Extremity Sensory Score (UESS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of the informed consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cardiopulmonary fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subjective success measured by Patient Global Impression-Improvement (PGI-I)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Technical success of procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical success of procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of adverse events attributable to the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: the volume of skin wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: the roughness of skin texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: the change of skin elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from Baseline Five Well Being Index (WHO-5) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline 9-item Patient Health Questionnaire - 9 (PHQ-9) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline 12-item Short Form survey version 2 (SF-12v2) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline 10-item General Self-Efficacy Scale (GSES-10) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility of protocol implementation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Therapist Rated Session Goal Attainment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Observer Rated Session Goal Attainment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Therapist Competence measured with CTS-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of ctDNA positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: lesion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: hemorrhage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Device-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post-operative delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Word Retrieval Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of improvement in wrinkling and elastosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of lesional demyelinated voxels classified as remyelinating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cumulative incidence of GVHD in its acute grade ≥ II and/or severe chronic form
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients achieving PASI 75 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Satisfaction with the Junior Leadership programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in IBD-related disability index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: difference in maximum activity (Bq/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet granule release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from Baseline in Muscle Mass to Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Handgrip Strength to Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with persistent postoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum tolerated dose of MCARH109 and MCARH125 T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health status self-rated score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mobility limitation score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-Report Tobacco Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient and clinician feedback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Technical goals confirmation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Biochemically-Verified Point Prevalence Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nicotine Relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of skill use in daily life
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Self-injurious urges, behaviors, and suicidal ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Emotion regulation/dysregulation changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in objective measures of cough sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Audiometric results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weighted electronic Driving Observation Schedule (eDOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-discharge follow-up PCP appointment completion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 12-month Disease Free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Skin Autofluorescence (SAF) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Colour change (Delta E)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in NAD+ level in whole blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overuse Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Health Problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma Tenofovir (TFV) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Emtricitabine (FTC) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral Blood Mononuclear Cell (PBMC) TFV-Diphosphate (TFV-DP) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral Blood Mononuclear Cell (PBMC) FTC-Triphosphate (FTC-TP) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse reaction within 28 days after each dose
Endpoint domain: Adverse events/effects